Drug Topics March 14, 2025
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discussed the common trends in GLP-1 use she’s seen amongst her patients as well as her extensive experience working with this medication class.
Glucagon-like peptide-1 (GLP-1) receptor agonists have been on the prescription drug market for around 20 years. However, with recent indications for obesity and other comorbidities in this medication class, GLP-1s have seen a significant rise in the past few years.
“When anything new comes out, at first, there are some people that really jump on board and want to try it and then others who have some hesitancy,” said Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, Endocrine Clinical Pharmacy Specialist with Cleveland Clinic Endocrinology & Metabolism Institute. “You hear sometimes...
Today's Sponsors
Today's Sponsor